Claims processed to date:12,960,971
Drug units and step-therapy denials cost rheumatology practices recoverable revenue every day.
Rheumatology runs on high-cost biologic infusions, the initial, sequential, and additional-hour administration hierarchy, and step-therapy documentation, where a single J-code, wastage modifier, or missing auth wipes out a high-dollar claim. Manual billing teams catch a fraction of the errors. Ember catches all of them.
2,700+ providers across 40+ states trust Ember AI
Where rheumatology revenue leaks
The denial patterns Ember was built for
Rheumatology runs high-cost biologic drugs, complex infusion administration, and step-therapy scrutiny side by side, and each line has its own denial trap. Drug units, infusion sequencing, and auth gaps compound into systematic underpayment. Ember closes each gap.
01 · Biologic drug units & wastage
J-code, unit, and wastage errors on high-cost infliximab and rituximab.
Infliximab, rituximab, and other biologics carry high per-dose cost, and the smallest J-code, unit, or wastage-modifier error becomes a denial or takeback on an expensive claim. Buy-and-bill margins disappear when JW and JZ modifiers don't match the documented dose. Ember validates units and documented wastage before the drug is billed.
J1745 · J9312 · J3357 · JW · JZ02 · Infusion administration hierarchy
Initial, sequential, and additional-hour codes miscoded against documented times.
Infusion administration follows a strict initial, sequential, and additional-hour hierarchy tied to documented start and stop times. When those codes are missed or transposed, a full infusion collapses into a partial payment. Ember maps the documented times to the correct administration codes before submission.
96413 · 96415 · 96361 · 9641703 · Prior auth & step therapy
Auth and documentation denials on biologics requiring failed DMARDs.
Payers require documented step therapy and failed conventional DMARDs before approving biologics, and auth obtained doesn't always match the payer's current policy. Documentation gaps trigger denials on high-value drug claims. Ember flags the missing criteria before the service and builds the appeal package when denials occur.
J1745 · J1602 · 96413 · L38246Three engines.
One source of truth.
Ember connects clinical documentation, payer policy, and contract terms into a single intelligence layer. Built for the buy-and-bill, infusion-hierarchy, and step-therapy mix rheumatology billing spans every day.
Audit upstream.
Appeal downstream.
Two workflows do most of the work for rheumatology practices. The first prevents denials before they happen. The second recovers the ones that slip through.
The full revenue cycle
From eligibility to adjudication. Covered.
Audit and appeals are the workhorses, but Ember protects rheumatology revenue at every stage of the cycle.
Eligibility Verification
Confirms active coverage and drug and infusion benefit structure before the visit, and flags buy-and-bill coverage gaps before they become billing problems.
Prior Authorization
Checks auth requirements in real time for biologics and confirms documented step therapy and failed conventional DMARDs, generates medical-necessity documentation, and submits to payer portals automatically.
AI Medical Coding
Reviews 100% of encounters, biologic drug units and wastage and the initial/sequential/additional-hour infusion hierarchy, against national standards and payer rules before claims submit.
Pre-bill Audit
Predicts and prevents denials before claims go out, catching drug-unit and wastage gaps, infusion-sequencing errors, and step-therapy issues before they generate write-offs.
Denial Management
Full appeal lifecycle for every rheumatology denial type, step-therapy dispute, medical necessity, drug auth failure, and units/wastage error, tracked to adjudication.
Underpayment Recovery
Parses contracts to model what each biologic and infusion claim should pay, then surfaces line-item underpayments on high-cost drug claims at scale.
High-dollar biologic revenue, recovered
-57%
denial rate
-45%
cost to collect
100%
encounters audited
7 days
to first results
Based on Ember AI benchmarks across customer practices. Results vary by payer mix and specialty.
Revenue leaders, on the record
What specialty practices and health systems say after putting Ember into production.
Frequently asked questions
Everything you need to know about how Ember fits into your revenue cycle.
See what your rheumatology practice is leaving on the table
Bring us 30 days of denial data. We'll show you where the revenue is and exactly how Ember would recover it.











